Defective HLA class I antigen processing machinery in cancer.

Cancer Immunology, Immunotherapy : CII
Lei CaiSoldano Ferrone

Abstract

Malignant transformation of cells is frequently associated with defective HLA class I antigen processing machinery (APM) component expression. This abnormality may have functional relevance, since it may have a negative impact on tumor cell recognition by cognate T cells. Furthermore, HLA class I APM abnormalities appear to have clinical significance, since they are associated with poor prognosis in several malignant diseases and may play a role in the resistance to immune checkpoint inhibitor-based immunotherapy. In this paper, we have reviewed the literature describing abnormalities in HLA class I APM component expression in many types of cancer. These abnormalities have been reported in all types of cancer analyzed with a frequency ranging between a minimum of 35.8% in renal cancer and a maximum of 87.9% in thyroid cancer for HLA class I heavy chains. In addition, we have described the molecular mechanisms underlying defects in HLA class I APM component expression and function by malignant cells. Lastly, we have discussed the clinical significance of HLA class I APM component abnormalities in malignant tumors.

References

Mar 1, 1976·Somatic Cell Genetics·H E FaberO Smithies
Mar 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·U Francke, M A Pellegrino
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·S B HoschK Pantel
Jul 1, 1997·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·S B HoschJ R Izbicki
Mar 10, 2001·International Journal of Cancer. Journal International Du Cancer·J KamarashevR Dummer
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·A SerranoF Garrido
Apr 22, 2003·International Journal of Cancer. Journal International Du Cancer·Ester FonsattiMichele Maio
May 18, 2006·Immunogenetics·Isabel MalenoFederico Garrido
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ester FonsattiMichele Maio
Sep 5, 2008·The New England Journal of Medicine·Steven A RosenbergNicholas P Restifo
May 19, 2010·World Journal of Gastroenterology : WJG·Rui-Qing PengXiao-Shi Zhang
Sep 13, 2011·Journal of Translational Medicine·Adrian BotFrancesco M Marincola
Mar 16, 2012·Nature Reviews. Cancer·Wolf Herman FridmanJérôme Galon
Jan 10, 2013·Current Opinion in Oncology·Michele MaioAlexander M M Eggermont
Feb 13, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jacky T YeungHideho Okada
Apr 4, 2015·Science·Padmanee Sharma, James P Allison
Jun 17, 2015·Biochimica Et Biophysica Acta·Gregg L Semenza
Aug 28, 2015·Journal of Translational Medicine·Lena SokolAlessandro Lugli
Sep 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francesco SabbatinoCristina R Ferrone
Feb 7, 2016·Journal of the National Cancer Institute·Francesco SabbatinoSoldano Ferrone
Apr 16, 2016·Nature Reviews. Cancer·Suzanne L TopalianDrew M Pardoll
Apr 29, 2016·Chinese Clinical Oncology·Wei DaiMaria Li Lung
Jul 20, 2016·The New England Journal of Medicine·Jesse M ZaretskyAntoni Ribas
Sep 25, 2016·Cold Spring Harbor Perspectives in Medicine·John D MartinRakesh K Jain

❮ Previous
Next ❯

Citations

Nov 9, 2018·Expert Review of Proteomics·Eric A Wilson, Karen S Anderson
Sep 18, 2020·Cellular and Molecular Life Sciences : CMLS·Yuan WeiDong-Ming Kuang
Sep 24, 2020·Leukemia & Lymphoma·Chantana PolprasertPonlapat Rojnuckarin
Feb 27, 2020·Viruses·Elena BuschChristine E Engeland
Nov 22, 2019·Immunotherapy·Roland AnderssonDaniel Ansari
Aug 4, 2019·Cancer Immunology, Immunotherapy : CII·Michael FriedrichBarbara Seliger
Aug 23, 2020·Journal of Clinical Medicine·Maria-Filothei LazaridouBarbara Seliger
Oct 8, 2020·International Journal of Molecular Sciences·Francesco SabbatinoStefano Pepe
Dec 5, 2020·Clinical Orthopaedics and Related Research·Shalin S PatelJoseph H Schwab
Sep 18, 2020·Cancer Immunology Research·Pouya FaridiAndreas Behren
Dec 14, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aura MuntasellJoan Albanell
Oct 15, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Filippos KontosSoldano Ferrone
Mar 18, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jordi RemonGiorgio V Scagliotti
Mar 9, 2021·Frontiers in Oncology·Bin ZhangPing Cheng
Mar 27, 2021·Frontiers in Immunology·Karthik DhatchinamoorthyKenneth L Rock
Apr 15, 2021·Nature Reviews. Gastroenterology & Hepatology·Bruno SangroIgnacio Melero
Feb 20, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ila J DatarKurt A Schalper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Angelica FacoettiSoldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Liz Y HanAnil K Sood
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Markus MeissnerBarbara Seliger
© 2022 Meta ULC. All rights reserved